Blood cancers

Umbilical cord blood cells fine for HSCT

The source of donor cells for haematopoietic stem cell transplants (HSCT) in children with AML does not appear to affect relapse rates, leukaemia-free survival or overall survival. An international study of 317 children who received HSCT between 2005 and 2015 at one of eight institutions including the Kids Cancer Centre in Sydney, found there were ...

Already a member?

Login to keep reading.

© 2021 the limbic